Ravi Shridhar, PhD
Radiation Oncology · Orlando, FLNPI 1356565261
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $136,410 of the $192,071 with a category attached, or 71.0%. 26 manufacturers reported payments, led by Boston Scientific at 57.1% of the total. Reporting peaked in 2023 at $72,673 and has fallen 73.9% since, to $18,953 in 2025. Among radiation oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 299 payments — averaging $642.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$110K
- AstraZeneca$46K
- Histosonics, Inc.$21K
- Novartis$4K
- Siemens Medical Solutions USA, Inc.$3K
- Delcath Systems$2K
- plus $6K from 20 others
Across 17 payments — averaging $7053.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$115K
- ABK Biomedical USA, Inc.$4K
- Novartis Pharma AG$959
What the payments were for
- Consulting fees$26,90514%
- Speaking & faculty fees$136,41071%
- Travel & lodging$16,4549%
- Food & beverage$12,3026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 132 | $109,597 |
| AstraZeneca | 52 | $45,871 |
| Histosonics, Inc. | 6 | $20,839 |
| Novartis | 12 | $3,753 |
| Siemens Medical Solutions USA, Inc. | 13 | $3,416 |
| Delcath Systems | 6 | $2,098 |
| Telix Pharmaceuticals | 10 | $1,745 |
| Bayer | 16 | $1,494 |
| Johnson & Johnson | 8 | $539 |
| Biocompatibles, Inc. | 9 | $536 |
| ABK Biomedical USA, Inc. | 9 | $504 |
| Mevion_medical_systems_inc | 2 | $293 |
| Elekta, Inc. | 3 | $222 |
| Conmed Corporation | 3 | $213 |
| Reflexion Medical, Inc. | 1 | $178 |
| Exelixis Inc. | 1 | $175 |
| GE HealthCare | 1 | $139 |
| AbbVie | 5 | $139 |
| Viewray Technologies Inc | 1 | $82 |
| Tersera Therapeutics LLC | 2 | $59 |
| Blue Earth Diagnostics | 2 | $39 |
| Merck | 1 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Varian Medical Systems, Inc. | 1 | $27 |
| Novocure Inc. | 1 | $26 |
| Accuray Incorporated | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraSphere Y90 Glass Microspheres 10 GBq$57,680
- IMFINZI$42,738
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$36,834
- GENERAL - THERAPIES$4,202
- THERASPHERE$4,128
- GENERAL PAIN MANAGEMENT$3,636
- Lutathera$3,312
- PLUVICTO$2,039
- Hepzato Kit$1,984
- Halcyon$1,959
- ILLUCCIX$1,909
- Varian Ethos Treatment Planning$1,669
- Nubeqa$1,140
- Xofigo$1,140
- TrueBeam$881
- PTS250$278
- Varian Treatment$178
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM$178
- AIRSEAL$150
- GENERAL EMBOLICS$150
How this compares
$192,071 in reported general payments places this provider in the 95th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 23 | $1,479 |
| Sucralfate | 42 | $1,396 |
| Tamsulosin Hcl | 51 | $670 |
| Ondansetron Hcl | 12 | $413 |
| Methylprednisolone | 49 | $400 |
| Prednisone | 63 | $355 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $291 |
| Ondansetron OdtOndansetron | 12 | $257 |
| Oxycodone Hcl | 18 | $216 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 14 | $214 |
| SsdSilver Sulfadiazine | 11 | $147 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Orlando
- Shravan KandulaOrlando$444K
- Akash NandaOrlando$165K
- Imran MohiuddinOrlando$93K
- Charles HodgeOrlando$34K
- Bridget KoontzOrlando$26K
- Justin RineerOrlando$11K
- Matthew BiagioliOrlando$10K
- Shiv DesaiOrlando$8K
- Nina JohnsonOrlando$7K
- Martin KeischMiami Shores$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.